Examination of protective efficacy of influenza by zanamivir among the staff of a medical facility: the 2nd trial

Examination of protective efficacy of influenza by zanamivir among the staff of a medical facility: the 2nd trial - Protective efficacy of influenza by zanamivir

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016200

Enrollment

100

Registered

2015-01-13

Start date

2015-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Interventions

inhalation of Zanamivir placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Workers in this hospital

Exclusion criteria

Exclusion criteria: persons who take immunosuppressants

Design outcomes

Primary

Measure	Time frame
To compare the rate of influenza infection between 2 groups of Zanamivir and pracebo	—

Countries

Japan

Contacts

Public ContactTaiji Matsuyama

IRB IRB

toshihiro.tanaka@alumni.utoronto.ca054-271-7177

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026